{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:58:15Z","timestamp":1753869495317,"version":"3.41.2"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated whether children with HLA\u2010DQ\u2010conferred risk for type 1 diabetes (T1D) have an altered immune response to the widely\u2010used enterovirus vaccine, namely poliovirus vaccine, and whether initiation of autoimmunity to pancreatic islets modulates this response. Neutralizing antibodies induced by the inactivated poliovirus vaccine against poliovirus type 1 (Salk) were analysed as a marker of protective immunity at the age of 18 months in a prospective birth cohort. No differences were observed in antibody titers between children with and without genetic risk for T1D (odds ratio [OR]\u2009=\u20090.90 [0.83, 1.06], <jats:italic>p<\/jats:italic>\u2009=\u20090.30). In the presence of the genetic risk, no difference was observed between children with and without islet autoimmunity (OR\u2009=\u20091.00 [0.78, 1.28], <jats:italic>p<\/jats:italic>\u2009=\u20091.00). This did not change when only children with the autoimmunity before 18 months of age were included in the analyses (OR\u2009=\u20091.00 [0.85, 1.18], <jats:italic>p<\/jats:italic>\u2009=\u20091.00). No effect was observed when groups were stratified based on autoantigen specificity of the first\u2010appearing autoantibody (IAA or GADA). The children in each comparison group were matched for sex, calendar year and month of birth, and municipality. Accordingly, we found no indication that children who are at risk to develop islet autoimmunity would have a compromised humoral immune response which could have increased their susceptibility for enterovirus infections. In addition, the proper immune response supports the idea of testing novel enterovirus vaccines for the prevention of T1D among these individuals.<\/jats:p>","DOI":"10.1002\/jmv.28707","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:00:29Z","timestamp":1679911229000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HLA\u2010DQ\u2010conferred risk for type 1 diabetes does not alter neutralizing antibody response to a widely used enterovirus vaccine, the poliovirus vaccine"],"prefix":"10.1002","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-5153","authenticated-orcid":false,"given":"Amir\u2010Babak","family":"Sioofy\u2010Khojine","sequence":"first","affiliation":[{"name":"Department of Virology, Faculty of Medicine and Health Technology Tampere University Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi P.","family":"Lehtonen","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine and Health Technology Tampere University Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noora","family":"Nurminen","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine and Health Technology Tampere University Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta E.","family":"Laiho","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine and Health Technology Tampere University Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Turku University Hospital Turku Finland"},{"name":"Faculty of Medicine, Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology University of Turku Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[{"name":"Department for Children and Adolescents Oulu University Hospital Oulu Finland"},{"name":"Department of Paediatrics, MRC Oulu University of Oulu Oulu Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Lempainen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Turku University Hospital Turku Finland"},{"name":"Immunogenetics Laboratory, Institute of Biomedicine University of Turku Turku Finland"},{"name":"Department of Clinical Microbiology Turku University Hospital Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Ilonen","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory, Institute of Biomedicine University of Turku Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine University of Helsinki Helsinki Finland"},{"name":"Pediatric Research Centre, New Children's Hospital Helsinki University Hospital Helsinki Finland"},{"name":"Tampere Centre for Child Health Research Tampere University Hospital Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Hy\u00f6ty","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine and Health Technology Tampere University Tampere Finland"},{"name":"Fimlab Laboratories Pirkanmaa Hospital District Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12370"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-020-04558-x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0667-0"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4177-z"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0619"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4561-y"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91270-3"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0620"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.706964"},{"issue":"8190","key":"e_1_2_9_11_1","first-page":"354","article-title":"Pancreatic islet\u2010cell damage in children with fatal viral infections","volume":"2","author":"Jenson AB","year":"1980","journal-title":"Lancet (London, England)"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4704-1"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1548281"},{"key":"e_1_2_9_14_1","unstructured":"Provention Bio Inc. (2021) A phase 1 first\u2010in\u2010human randomized double\u2010blind placebo\u2010controlled multiple\u2010dose\u2010escalation study to evaluate the safety tolerability and immunogenicity of PRV\u2010101 a Coxsackie virus B (CVB) vaccine in healthy adult subjects clinicaltrials.gov"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60687-8_2"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz2433"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0193"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19107"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34309"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667889"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.102982"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.108"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.057"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep32899"},{"issue":"5","key":"e_1_2_9_25_1","first-page":"52","article-title":"Immunity to poliovirus after vaccination of children with T1D mellitus and rheumatic diseases","author":"Tarasova AA","year":"2009","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.09.008"},{"key":"e_1_2_9_27_1","unstructured":"WHO Enterovirus 71.https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccine-standardization\/enterovirus-71Accessed 12 Sep 2022"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.01.023"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3436-0"},{"key":"e_1_2_9_30_1","unstructured":"WHO Protocol for notification risk assessment and response following detection of poliovirus type 2 following globally\u2010coordinated cessation of serotype 2\u2010containing oral polio vaccine(2015) https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA71\/A71_R16-en.pdf"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3514-y"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61309-4"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12327"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.12.2049"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0878"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6285"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.3402\/ijch.v66i5.18310"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi033"},{"volume-title":"Guidelines for WHO\/EPI collaborative studies on poliomyelitis: standard procedure for determining immunity to poliovirus using the microneutralization test","year":"1993","author":"WHO Expanded Programme on Immunization","key":"e_1_2_9_39_1"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00057"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4946.19.05678-0"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5220"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0880"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.751337"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.28707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:56:08Z","timestamp":1692258968000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.28707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1002\/jmv.28707"],"URL":"https:\/\/doi.org\/10.1002\/jmv.28707","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"type":"print","value":"0146-6615"},{"type":"electronic","value":"1096-9071"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28707"}}